-
NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions
2019-11-29
NMPA has formulated,in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.
-
NMPA Issued the Announcement on Enabling the New Version of Management System for Import Filing of Drugs and Medicinal Materials
2019-12-19
NMPA and the General Administration of Customs have collaboratively established a management system for import filing of pharmaceuticals and medicinal material imports.
-
NMPA Issued the Notice on Enabling the Import and Export Permit Management System
2019-12-27
NMPA issued the Notice on Enabling the Import and Export Permit Management System, which clearly states that the drug import and export permit management system has been officially launched since December 25, 2019.
-
NMPA issued the Announcement on Enabling the Pharmaceutical Business Application System
2019-12-31
NMPA has integrated the development of a drug business application system to this end,covering the certificates for drug export sales,APIs exporting to EU drug substance,import and export of narcotic drugs and psychotropic substances,and the initial import of medicinal materials,etc.
-
The State Council Executive Meeting Passed the Regulation for Supervision of Cosmetics (Draft)
2020-01-06
On January 3, 2020, Premier Li Keqiang presided over an executive meeting of the State Council. In the meeting, the Regulation for Supervision of Cosmetics (Draft) was approved.
-
NMPA Issued the Administrative Measures for Key Laboratories of NMPA
2020-01-06
NMPA has organized the formulation of and released on January 6,2020 the Administrative Measures for Key Laboratories of NMPA.
